Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus.

No Thumbnail Available
Date
2005-08-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Neuropsychiatric abnormalities frequently occur in patients with systemic lupus erythematosus, affecting as many as 14-75% of people with this disease. High-dose steroid with or without anticoagulation is the mainstay of treatment in neuropsychiatric systemic lupus erythematosus (NPSLE). Use of mycophenolate as a steroid sparing drug may be a potential alternative agent in the therapy of NPLE, but lack of randomized trials and cost prohibit its widespread use. Its safety profile is higher than that of cyclophosphamide and azathioprine. We report a successfully treated case of neuropsychiatric systemic lupus erythematosus, presenting as psychosis, whose long-term remission was maintained on treatment with mycophenolate mofetil.
Description
Keywords
Citation
Jose J, Paulose BK, Vasuki Z, Danda D. Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus. Indian Journal of Medical Sciences. 2005 Aug; 59(8): 353-6
URI
https://imsear.searo.who.int/handle/123456789/67924
Collections
Indian Journal of Medical Sciences